Business
Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.
UCB, a global biopharmaceutical company, today announced that 15 scholarships were awarded to people impacted by myasthenia gravis in the U.S. The UCB Myasthenia Gravis Scholarship™ exemplifies UCB's dedication to supporting the rare disease community that goes beyond medicine. Living with or supporting a loved one impacted by this rare disease can be challenging. This scholarship program can help ease the costs associated with education and allow recipients to gain new skills to further their c
About this update from Ucb S.a.
[{"type":"text","content":"ATLANTA, June 17, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that 15 scholarships were awarded to people impacted by myasthenia gravis in the U.S. The UCB Myasthenia Gravis Scholarship™ exemplifies UCB's dedication to supporting the rare disease community that goes beyond medicine. Living with or supporting a loved one impacted by this rare disease can be challenging. This scholarship program can help ease the costs associated with education and allow recipients to gain new skills to further their career goals.","length":560,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/UCB, Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/UCB, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":95,"url":"https://media.zenfs.com/en/prnewswire.com/b8934a241b3f4be76014bb4ac3438a0c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xSTzopCi9exEzsCW8PHvIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE2NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b8934a241b3f4be76014bb4ac3438a0c","width":400,"height":95}},"href":"https://mma.prnewswire.com/media/677397/With_Tag_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This year's 15 scholarship recipients are a diverse group of passionate advocates including people living with MG or caregiving for a parent living with MG. Of the awardees, one-third are graduating high school seniors, with the remainder planning to pursue undergraduate or graduate degrees and certification programs.","length":328,"tagName":"p"},{"type":"text","content":""We are so honored to have received such outstanding applications from all over the country. UCB is inspired by the stories not only of the 15 recipients, but of all the applicants. UCB is driven to take meaningful action to meet their unmet needs," said Kim Moran, SVP & Head, U.S. Rare Diseases, UCB. "That's why we are also excited to announce that the company will continue to fund the UCB U.S. Myasthenia Gravis Scholarship into 2026."","length":468,"tagName":"p"},{"type":"text","content":""Financially, I face significant challenges as I juggle the costs of school, living expenses, and medical treatments. With this assistance, I can continue to pursue my dream of becoming a nurse and use my experiences to i...